Research and Development Status and Progress of Antibody Technology (Part Ⅱ)
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
July 18, 2024
by Xiaomichong
Research and Development Status and Progress of Antibody Technology (Part I)
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
July 18, 2024
by Xiaomichong
ProBioGen’s Growth Strategy Continues Successfully
In line with this growth, three crucial positions have been filled. These appointments reflect the company's commitment to continued growth.
March 6, 2023
by PharmaSources
Cold Chain Market 2021 2026 - Global Overview by Component, Logistics, Technology, Temperature Type, Type, Deployment Type, Application, and Region
The "Cold Chain Market Research Report by Component, Logistics, Technology, Temperature Type, Type, Deployment Type, Application, and Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report...
December 7, 2021
by prnewswire
Schrödinger, Bayer collaborate to co-develop de novo design technology to accelerate drug discovery
Schrödinger and Bayer announced a five-year technology alliance to develop a comprehensive de novo design solution with the objective to accelerate the discovery of innovative high-quality drugs.
January 13, 2020
by americanpharmaceuticalreview
Announcement of collaborative research agreement with National Cancer Center on analy sis of gut bacteria related to cancer
bitBiome, Inc. (Representative Director: Yoshihito Daimon, "bitBiome") and National Cancer Center of Japan (President...
December 10, 2019
by biopharmadive
Announcement of collaborative research agreement with National Cancer Center on analy sis of gut bacteria related to cancer
bitBiome, Inc. (Representative Director: Yoshihito Daimon, "bitBiome") and National Cancer Center of Japan (President...
December 10, 2019
Ping An Good Doctor and Merck Form Strategic Collaboration to Advance Intelligent Healthcare in China
Ping An Healthcare and Technology Company Limited (Stock code: "Ping An Good Doctor"...
December 10, 2019
by biopharmadive
Blockchain technology in healthcare market to hit $1.6bn by 2025
According to a new report, blockchain technology in the healthcare market size is set to increase exponentially.
September 16, 2019
by europeanpharmaceuticalreview
Colorcon, TruTag Technologies Partner on Authentication Technology
Combines TruTag’s silica-based microtag authentication technology with Colorcon’s expertise in film coating systems, modified release technologies, and specialty excipients.
August 8, 2019
by contractpharma
Cytena GmbH Announces That It Has Been Entered into an Agreement to Be Acquired by CELLINK
The owners of Cytena GmbH have agreed to sell all Cytena shares to CELLINK AB for a purchase price of 30.25M euros ("acquisition").
August 7, 2019
by b3cnewswire
Abzena Completes ADC Tech Transfer
Successful technical transfer of Synaffix GlycoConnect ADC Technology to enable use in client projects.
July 24, 2019
by contractpharma